Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 22 of 37
Health
What you need to know about severe reactions to COVID vaccines
By
John Lauerman
,
Jason Gale
and
Bloomberg
February 15, 2021
Health
Iceland wants Pfizer to conduct a nationwide COVID-19 study. There’s just one problem: it has too few cases.
By
Kristen V. Brown
,
Ragnhildur Sigurdardottir
and
Bloomberg
February 15, 2021
Health
How each U.S. state is doing when it comes to COVID vaccine distribution
By
Erika Fry
and
Nicolas Rapp
February 11, 2021
Health
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By
Riley Griffin
and
Bloomberg
February 10, 2021
Health
J&J’s COVID vaccine could make its global debut as soon as next week
By
David Meyer
February 10, 2021
Health
The AstraZeneca COVID-19 vaccine (and possibly others) are ineffective against the South African variant
By
Jeremy Kahn
February 8, 2021
Health
How to stop vaccine nationalism from prolonging the pandemic
By
David Meyer
February 7, 2021
Health
University of Oxford finds AstraZeneca vaccine effective on British variant
By
Eric Pfanner
,
James Paton
and
Bloomberg
February 5, 2021
Leadership
What happened at Fortune’s not-in-Davos gathering of business leaders
By
Fortune Editors
February 3, 2021
Health
The AstraZeneca vaccine cuts COVID transmission—and delaying the second dose is a good idea, study finds
By
Jeremy Kahn
February 3, 2021
Magazine
Pfizer’s CEO thinks a vaccine-resistant COVID variant is ‘likely’—but that’s not as scary as it sounds
By
Clifton Leaf
February 3, 2021
Health
Why Europe’s summer COVID vaccination target could still be on track
By
David Meyer
February 1, 2021
Health
With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By
Jeremy Kahn
and
David Meyer
January 29, 2021
Leadership
Pfizer is investing in a ‘surveillance network’ to detect coronavirus variants
By
Beth Kowitt
January 29, 2021
Health
Biden Administration pledges to order additional 200 million doses and speed up pace of vaccinations
By
Josh Wingrove
,
Mario Parker
and
Bloomberg
January 27, 2021
Most Popular
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put her on the path give more than $1...
By
Sasha Rogelberg
Future of Work
Malcolm Gladwell tells young people if they want a STEM degree, 'don’t go to Harvard.' You may end up at the bottom of...
By
Sasha Rogelberg
Arts & Entertainment
Gen Zers and millennials flock to so-called analog islands 'because so little of their life feels tangible'
By
Michael Liedtke
and
The Associated Press